Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
KW 3902 is an adenosine A1-receptor antagonist, which has recently been shown to alleviate axonopathy caused by human Tau ΔK280. KW 3902 can be considered for the development of a treatement towards hypometabolism and neuronal dysfunction associated with Tau-induced neurodegenerative diseases.
您的位置：
